Selvita to Host Conference Call and Webcast on Thursday, March 28

Krakow, Poland – 21 March 2019 – Selvita (WSE:SLV), a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced that it will report fourth quarter and year end 2018 financial results on Thursday, March…

More

Selvita to Exhibit at the 3rd Annual Drug Discovery Chemistry Conference

Krakow, Poland – 11 March 2019 – Selvita, drug discovery and development partner for the pharmaceutical and biotechnology industries, today announces that it is a proud sponsor and exhibitor at the upcoming 3rd Annual Drug Discovery Chemistry conference taking place on the 18-19th of March 2019, in London, UK.  …

More

Selvita to Present at Biotech Showcase 2019 in San Francisco

Krakow, Poland – 2 January 2019 – Selvita (WSE:SLV), a clinical stage drug discovery and development company engaged in the research and development of novel cancer therapies, today announced that Chief Executive Officer Pawel Przewiezlikowski will present a corporate overview at the Biotech Showcase 2019 conference taking place Jan. 7-9…

More